Literature DB >> 16290921

Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.

Fuli Liu1, Yajun Cheng, Jun Wu, Horst-Dietmar Tauschel, Rui-Dong Duan.   

Abstract

We investigated the effects of UDCA on sphingomyelinase (SMase) in Caco 2 cells cultured in monolayer and polarized conditions. Alkaline SMase activity was high in polarized cells whereas, acid and neutral SMase activities were high in monolayer cells. In polarized cells, UDCA increased alkaline SMase expression and caspase 3 activity but had no effect on acid and neutral SMases. In monolayer cells, UDCA reduced both acid and neutral SMase activities, inhibited cell proliferation, but had little effect on alkaline SMase and caspase 3 activities. In conclusion, UDCA differentially affects SMase activity, cell proliferation, and apoptosis in colonic cells depending on the cell conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16290921     DOI: 10.1016/j.canlet.2005.04.016

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  A high-throughput sphingomyelinase assay using natural substrate.

Authors:  Miao Xu; Ke Liu; Noel Southall; Juan J Marugan; Alan T Remaley; Wei Zheng
Journal:  Anal Bioanal Chem       Date:  2012-06-19       Impact factor: 4.142

Review 2.  Ceramide signaling in the gut.

Authors:  Ying Li; Rebekah J Nicholson; Scott A Summers
Journal:  Mol Cell Endocrinol       Date:  2022-01-05       Impact factor: 4.102

Review 3.  Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology.

Authors:  Catherine Pavoine; Françoise Pecker
Journal:  Cardiovasc Res       Date:  2009-01-28       Impact factor: 10.787

4.  Lysosomal ceramide mediates gemcitabine-induced death of glioma cells.

Authors:  Claudia A Dumitru; Ibrahim E Sandalcioglu; Marek Wagner; Michael Weller; Erich Gulbins
Journal:  J Mol Med (Berl)       Date:  2009-09-10       Impact factor: 4.599

Review 5.  Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases: A field that needs to be closely studied.

Authors:  Rui-Dong Duan
Journal:  World J Hepatol       Date:  2018-02-27

6.  Ursolic acid inhibits the formation of aberrant crypt foci and affects colonic sphingomyelin hydrolyzing enzymes in azoxymethane-treated rats.

Authors:  David Andersson; Yajun Cheng; Rui-Dong Duan
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-29       Impact factor: 4.322

7.  Identification of aberrant forms of alkaline sphingomyelinase (NPP7) associated with human liver tumorigenesis.

Authors:  Y Cheng; J Wu; E Hertervig; S Lindgren; D Duan; A Nilsson; R-D Duan
Journal:  Br J Cancer       Date:  2007-10-09       Impact factor: 7.640

Review 8.  Metabolism, physiological role, and clinical implications of sphingolipids in gastrointestinal tract.

Authors:  Krzysztof Kurek; Bartłomiej Łukaszuk; Dominika M Piotrowska; Patrycja Wiesiołek; Anna Małgorzata Chabowska; Małgorzata Zendzian-Piotrowska
Journal:  Biomed Res Int       Date:  2013-09-05       Impact factor: 3.411

9.  Mevalonate inhibits acid sphingomyelinase activity, increases sphingomyelin levels and inhibits cell proliferation of HepG2 and Caco-2 cells.

Authors:  Ying Chen; Shu-Chang Xu; Rui-Dong Duan
Journal:  Lipids Health Dis       Date:  2015-10-22       Impact factor: 3.876

Review 10.  Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart.

Authors:  Noorul Izzati Hanafi; Anis Syamimi Mohamed; Siti Hamimah Sheikh Abdul Kadir; Mohd Hafiz Dzarfan Othman
Journal:  Biomolecules       Date:  2018-11-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.